Position in ESPR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$0
+$0 QoQ
Shares Held
2,225,733
+268.3% QoQ
Ownership
0.865%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ESPR Over Time
Shares Held
Position Value (USD)
Derivatives in ESPR
reported options exposure · as of Jun 30, 2024CallValue
$0
CallShares
300,000
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MILLENNIUM MANAGEMENT LLC holds $1,140,219,030 across 49 Drug Manufacturers - Specialty & Generic names. ESPR ranks #49 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
409,074 | $221,648,565 | |
| 2 | SUPN |
Supernus Pharmaceuticals, Inc.
|
3,853,212 | $179,212,890 | |
| 3 | ZTS |
Zoetis Inc.
|
1,813,759 | $130,336,721 | |
| 4 | TEVA |
Teva Pharmaceutical Industries Ltd
|
3,265,321 | $110,629,075 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
2,098,945 | $86,119,713 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,725,889 | $67,084,128 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
507,207 | $41,986,595 | |
| 8 | LNTH |
Lantheus Holdings, Inc.
|
336,399 | $37,320,105 |
All Filings in ESPR
Export CSV
35 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | — | 2,225,733 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | — | 604,345 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | — | 3,932,274 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | — | 974,856 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | — | 452,650 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | — | 961,035 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | — | 829,885 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | — | 3,403,530 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | — | 300,000 | Call | Sole | 2024-08-14 | |
| 2024-06-30 | — | 6,513,932 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | — | 5,681,744 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | — | 3,449,451 | Shares | Sole | 2024-02-14 | |
| 2023-12-31 | — | 194,500 | Call | Sole | 2024-02-14 | |
| 2023-09-30 | — | 5,794,029 | Shares | Sole | 2023-11-14 | |
| 2023-09-30 | — | 200,000 | Call | Sole | 2023-11-14 | |
| 2023-06-30 | — | 200,000 | Call | Sole | 2023-08-14 | |
| 2023-06-30 | — | 3,346,726 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | — | 500,000 | Call | Sole | 2023-05-15 | |
| 2023-03-31 | — | 3,675,274 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | — | 247,500 | Call | Sole | 2023-02-14 | |
| 2022-12-31 | — | 2,226,809 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | — | 1,723,175 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | — | 2,706,290 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | — | 1,248,338 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | — | 334,430 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | — | 467,298 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | — | 316,933 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | — | 50,000 | Call | Sole | 2021-05-17 | |
| 2021-03-31 | — | 322,614 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | — | 139,041 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | — | 50,000 | Call | Sole | 2020-11-16 | |
| 2020-09-30 | — | 266,133 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | — | 100,000 | Call | Sole | 2020-08-14 | |
| 2020-06-30 | — | 529,139 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | — | 85,165 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||